Identity
- Security key
- 18401
- Ticker
- MCRB
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2015-06-26
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- MCRB
Detail
Enriched 2026-08-14 20:47
- Market cap
- $47,411,366.32
- Shares outstanding (class)
- 9,941,261
- Shares outstanding (weighted)
- 10,044,781
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 66
- Location
- CAMBRIDGE, MA
- Description
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Market cap and share counts drift.